XTLB
X.T.L. Biopharmaceuticals Ltd. ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.60
-0.03 ▼ -4.76%
🌙 3월 13일 4:22 PM ET (한국 3/14 05:22)
$0.57
-0.03 ▼ -4.42%
| Index | - | P/E | - | EPS (ttm) | -0.11 | Insider Own | 2.46% | Shs Outstand | 0.01B | Perf Week | -17.59% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.01B | Perf Month | -33.43% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | - | Inst Own | 3.48% | Short Float | 0.72% | Perf Quarter | -28.01% |
| Income | -0.00B | P/S | 12.61 | EPS this Y | - | Inst Trans | 10.28% | Short Ratio | 0.09 | Perf Half Y | -56.99% |
| Sales | 0.00B | P/B | 0.97 | EPS next 5Y | - | ROA | -18.78% | Short Interest | 0.07M | Perf YTD | 3.45% |
| Book/sh | 0.62 | P/C | 4.98 | EPS past 3/5Y | - 10.17% | ROE | -26.93% | 52W High | -76.65% ($2.57) | Perf Year | -52% |
| Cash/sh | 0.12 | P/FCF | - | Sales past 3/5Y | - | ROIC | -18.96% | 52W Low | 13.19% ($0.53) | Perf 3Y | -51.22% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 65.58% | Gross Margin | 0.62% | Volatility(W/M) | 10.52% 12.89% | Perf 5Y | -82.3% |
| Dividend TTM | - | EV/Sales | 10.39 | Sales Y/Y TTM | - | Oper. Margin | -480.57% | ATR (14) | 0.1 | Perf 10Y | -91.18% |
| Dividend Ex-Date | - | Quick Ratio | 0.61 | EPS Q/Q | 44.49% | Profit Margin | -227.13% | RSI (14) | 31.29 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.61 | Sales Q/Q | - | SMA20 | -21.8% ($0.77) | Beta | 1.24 | Target Price | $6 |
| Payout | - | Debt/Eq | 0.03 | Earnings | - | SMA50 | -27.67% ($0.83) | Rel Volume | 0.05 | Prev Close | $0.63 |
| Employees | 11 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -45.69% ($1.1) | Avg Volume(3M) | 0.73M | Price | $0.6 |
| IPO | 2005/9/1 | Option/Short | No/Yes | Trades | 1472 | Volume | 35,637 | Change | -4.76% |
뉴스 로딩 중...